Arturo Loaiza-Bonilla, MD, MSEd, FACP, discussed the ability of large foundational artificial intelligence (AI) models to democratize pathology readouts by providing biomarkers with an H&E stain or a slide in the absence of readily available pathologist in an interview with CancerNetwork®. He suggested that having the ability to deploy an algorithm via the cloud would help to facilitate initial screenings for patients. Loaiza-Bonilla is the systemwide chief of Hematology and Oncology at Saint Luke’s University Health Network.
AI's Role in Pathology Democratization
Dr. Arturo Loaiza-Bonilla emphasizes the potential of large foundational AI models to democratize pathology by providing biomarker readouts from H&E stains or slides, crucial in settings where pathologists are not readily available.
Enhancing Initial Cancer Screenings
The discussion points to the advantage of deploying AI algorithms through cloud technology to streamline and improve initial cancer screenings for patients, making diagnostics more accessible.
Expert's Affiliation and Expertise
The article features insights from Dr. Arturo Loaiza-Bonilla, who is the systemwide chief of Hematology and Oncology at Saint Luke’s University Health Network, underscoring his expertise in the field of oncology and AI applications.
